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Available online 30 November 2010AbstractAntimicrobial resistance patterns and molecular characteristics were determined in thirty-two Shiga-toxin-producing Escherichia coli
(STEC) strains previously identified in Sa˜o Paulo State associated with human infections (n ¼ 21) and in cattle feces (n ¼ 11). The highest
resistance rates were identified for tetracycline (100%), streptomycin (78%) and trimethoprimesulfamethoxazole (56%). Eleven STEC strains
showed resistance to ampicillin and carried blaTEM that was confirmed as blaTEM-1 in one representative isolate. The class 1 integrase gene
(intI1) was detected in seven (22%) strains, and most of them belonged to the O111:H8 serotype. The class 1 integron was located on plasmids in
five of the seven STEC strains, and conjugation assays confirmed the plasmid support of those resistant determinants. STEC strains were
genetically classified into the B1 group, and PFGE analysis showed that most of the strains in each serogroup were grouped into the same cluster
(80e97% similarity). The presence of a class 1 integron and blaTEM-1 genes is described for the first time among STEC isolates in Brazil and
clearly represents a public health concern.
 2010 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
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Shiga-toxin-producing Escherichia coli (STEC) strains are
an important group of food-borne pathogens that cause a broad
range of manifestations, including hemorrhagic colitis and
hemolytic uremic syndrome (Nataro and Kaper, 1998). STEC
colonize the gastrointestinal tract of domestic and wild
animals, but ruminants are regarded as the main natural
reservoirs (Beutin et al., 1993, 1997). The consumption of
contaminated foods of animal origin is one of the major causes
of STEC infection in humans (Cergole-Novella et al., 2006).
Although antimicrobial therapy is not the primary tool for* Corresponding author. Tel.: þ55 11 5083 2980; fax: þ55 11 5572 4711.
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doi:10.1016/j.resmic.2010.09.022treating infections caused by STEC, some reports indicate that
antimicrobial resistance of STEC is on the rise (White et al.,
2002). The use of antimicrobial agents in the agricultural
environment is believed to play a key role in the dissemination
of resistance genes among bacteria, and it has been suggested
that the overuse of antibiotics in animal husbandry creates
a threat to human and animal health. Antimicrobial resistance
determinants are carried mostly by mobile genetic elements
such as plasmids, transposons and integrons. A possible role of
integrons and conjugative plasmids in the dissemination of
genes conferring antibiotic resistance from pathogenic to
generic E. coli cells has been suggested (Nagachinta and
Chen, 2009).
A high prevalence of integronswas detected in fecalE. coli of
healthy humans, demonstrating that individuals in the commu-
nity could be a reservoir of integron-containing E. coli isolates
(Vinue´ et al., 2008). Several studies have demonstrated thatsson SAS. All rights reserved.
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genes between human and animal bacteria and also the sharing
of phylogenetic and genotypic similarities (Van Den Bogaard
and Stobberingh, 2000). Extended-spectrum b-lactamases
(ESBLs) have contributed to the recently noted large increase in
resistance to b-lactams. Many of the ESBLs arise from point
mutations in plasmid-mediated genes that encode narrow-
spectrumb-lactamases such as TEMandSHV (Bradford, 2001).
However, members of a newly emerging ESBL group, CTX-M,
derived from class A chromosomal b-lactamases have been
identified (Bonnet, 2004). In Japan, Kon et al. (2005) described
an STEC O26:H11 strain resistant to cefotaxime and cefpo-
doxime (but not ceftazidime), producing CTX-M-3 type ESBL.
Despite the fact that antimicrobial resistance in STEC has been
the subject of several studies, information on themolecular basis
of antimicrobial resistance among this zoonotic group of
bacteria is still limited (Guerra et al., 2006; Lee, 2009;
Nagachinta and Chen, 2009; Srinivasan et al., 2007; Zhao
et al., 2001). The aims of this study were to further charac-
terize the antimicrobial resistance displayed by various STEC
strains isolated from human infections and the animal reservoir
in Brazil, and evaluate their genetic relatedness.
2. Materials and methods2.1. Bacterial strainsA total of 32 antimicrobial-resistant STEC strains (Cergole-
Novella et al., 2006) belonging to non-O157 serotypes isolated
in Sa˜o Paulo, Brazil, were investigated in this study. Twenty-
one STEC strains were isolated from humans with diarrhea
(Guth et al., 2002; Irino et al., 2007; Vaz et al., 2004), and 11
were isolated from cattle (Aidar-Ugrinovich et al., 2007; Irino
et al., 2005; Leomil et al., 2003; Salvadori et al., 2003).2.2. Antimicrobial susceptibility testingMinimum inhibitory concentrations (MICs) were deter-
mined by agar dilution of 12 antimicrobial agents according to
Clinical and Laboratory Standards Institute (CLSI, 2007)
guidelines. The antimicrobials tested were: nalidixic acid
(Nal), ampicillin (Amp), kanamycin (Kan), cefepime (Cef),
cefotaxime (Ctx), ceftazidime (Cfz), ciprofloxacin (Cip),
chloramphenicol (Chlo), streptomycin (Str), gentamicin
(Gen), trimethoprimesulfamethoxazole (Sut) and tetracycline
(Tet).2.3. Phylogenetic grouping and pulsed-field gel
electrophoresis typing (PFGE)Triplex PCR profiles specific for E. coli phylogenetic
groups were performed with specific primers according to
Clermont et al. (2000). The macrorestriction analysis of
genomic DNA with XbaI described by Gautom (1997) was
used with some modifications for PFGE. The digestion time
was extended to 16 h, and PFGE was performed using
a CHEF-DRIII PFGE apparatus (Bio-Rad). The pulse timewas increased from 5 to 50 s over a 19-h period. The band
patterns were analyzed by the BioNumerics program version
5.1 (Applied Maths), and the similarity between PFGE
patterns was evaluated using the Dice similarity coefficient
(tolerance, 1.5%).2.4. PCR, PCReRFLP and nucleotide sequencing of
intl1/qacED1 and blaTEMThe presence of integrase associated with class 1 integrons
(intI1) (50 GTT CGG TCA AGG TTC TGG 30 and 50 GTA
GAG ACG TCG GAATGG 30; 94 C, 60 s; 67 C, 60 s; 72 C,
60 s; 35 cycles; 889 bp), blaTEM (Rasheed et al., 1997),
intl1/qacED1 (Castanheira et al., 2004), aadA and tetA (Enne
et al., 2008) was assayed by PCR. PCReRFLP assay was
carried out using specific primer sequences of intl1/qacED1
followed by 3 h of digestion with HaeIII. Amplicons were
sequenced on both strands. Nucleotide and deduced amino
acid sequences were analyzed using the Lasergene software
package (DNASTAR, Madison, WI) and compared with
sequences available through the Internet using BLAST (http://
www.ncbi.nlm.nih.gov/blast/).2.5. Plasmid characterization and transfer of resistancePlasmid DNA was extracted by the Birnboim and Doly
(1979) alkaline lysis method and analyzed by electrophoresis
in agarose gels. Plasmid masses were estimated by using E coli
strain 39R861 with known molecular size plasmid bands as
marker. In addition, Southern blot hybridization assays with an
intI1-specific probe were also performed using Amersham ECL
direct nucleic acid labelling and detection systems (GE
Healthcare). To investigate the transfer of plasmids identified as
carriers of resistance markers, one representative STEC strain
(Ec120/00) was selected, and conjugation assays were per-
formed using a spontaneous mutant resistant to nalidixic acid of
commensal E. coli HS strain (Levine et al., 1978) as the recip-
ient. The transconjugants were selected on nutrient agar con-
taining tetracycline (25 mg/mL) and nalidixic acid (100 mg/mL),
while the donor strain was selected by plating a dilution of the
conjugation mixture onto nutrient agar containing tetracycline.
Successful introduction of the plasmid was determined by disc
diffusion, plasmid extraction and visualization by agarose gel
electrophoresis, and PCR amplification.
3. Results3.1. Antimicrobial resistance profile of STEC strainsTwenty-one (65.6%) of 32 STEC isolates were resistant to
three or more classes of antimicrobials (Table 1). The highest
resistance rates were noted for tetracycline (100%), strepto-
mycin (78.1%) and trimethoprimesulfamethoxazole (56.2%).
However, resistance to ampicillin (34.4%) and kanamycin
(37.5%) was also identified. The 11 STEC strains resistant
to ampicillin possessed blaTEM. The blaTEM gene of one
Table 1
Characteristics of antimicrobial-resistant STEC strains.
STEC strain Serotype Origina stx intl1 Antimicrobial profileb Phylogenetic group
Ec36/01/87 O26:H11 HD 1 e Tet B1
2567/81 O26:H11 HD 1 e StrTet B1
16FB(12) O55:H19 DC 1 e AmpChloKanStrTet B1
775/93 O111:H8 HD 1 e AmpChloKanStrSutTet B1
5780/76 O111:H8 HD 1 e Tet B1
21/85 O111:H8 HD 1 þ AmpChloStrSutTet B1
1731-3 O111:H8 HD 1 e StrSutTet A
2781-8 O111:H8 HD 1 þ StrChloSutTet B1
19/79 O111:H8 HD 1 e Tet B1
Ec120/00 O111:H8 HD 1 þ StrTet B1
Ec464/01 O111:H8 HC 1 þ 2 e SutTet B1
BP/25B1 O111:H8 DC 1 e AmpKanStrSutTet B1
BP/2HV4 O111:H8 DC 1 e AmpKanStrSutTet B1
BP/61C7-4 O111:H8 HC 1 e AmpKanStrSutTet B1
BP/F5-1 O111:H8 HC 1 e StrSutTet B1
BP/B4 O111:H8 HC 1 e ChloStrSutTet B1
BP/M2-1 O111:H8 DC 1 e StrSutTet B1
Ec256/03 O111:H8 HD 1 e AmpChloStrSutTet B1
3691-5 O111:H8 HD 1 þ StrTet B1
1919/81 O111:H11 HD 1 þ StrTet B1
490/78 O111:HNM HD 1 e Tet B1
502/80 O111:HNM HD 1 þ ChloKanStrTet B1
Ed 19/00 O111:HNM HD 1 e AmpChloKanStrSutTet B1
Ec54/87 O111:HNM HD 1 e Kan StrTet B1
288/83 O111:HNM HD 1 e Tet B1
27/86 O111:HNM HD 1 e StrSutTet B1
BY-1 O118:H16 DC 1 þ AmpChloKanStrSutTet B1
937BGc O118:H16 DC 1 e AmpKanStrSutTet B1
1157/89 O118:H16 HD 1 e StrSutTet B1
44/01 ONT:H2 HD 1 e AmpKanStrTet B1
Ec586/03 ONT:H2 HD 1 e KanStrSutTet B1
Ec248/02 ONT:H49 HC 1 þ 2 e Tet B1
a HD, human with diarrhea; DC, feces from diarrheic cattle; HC, feces of healthy cattle.
b Amp, ampicillin; Chlo, chloramphenicol; Kan, kanamycin; Str, streptomycin; Tet, tetracycline; Sut, trimethoprimesulfamethoxazole.
c Multidrug-resistant O118:H16 STEC strain previously described in South America (Castro et al., 2003).
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sequenced confirming the presence of blaTEM-1.3.2. Phylogenetic grouping and PFGEPhylogenetic grouping classified all strains except one,
O111:H8, into the B1 group (Table 1). The PFGE typing of
O111 and O118 STEC strains showed a diversity of profiles
(Fig. 1), but O111 STEC strains were grouped into three
distinct clusters with more than 80% similarity.3.3. Presence of the intl1 gene in the STEC strainsThe integrase gene associated with class 1 integrons was
found in 22% of STEC. Six human STEC strains that carry the
class 1 integron belonged to theO111 serogroup, and one bovine
STEC strain belonged to theO118 serogroup (Table 1). Analysis
of integrons by PCReRFLP revealed identical profiles in four
(Ec120/00, 3691-5, 1919/81 and 502/80) of the seven STEC
strains (data not shown). These four integrons had a uniform size
and contained a single gene cassette, aadA1 (streptomycin
resistance), in their variable region (intl1FeaadA1eqacED1R),as determined by nucleotide sequencing. In addition, these
strains showed resistance to streptomycin and had high MICs
(64 mg/mL).3.4. Plasmid characterization and transfer of resistance
by conjugation of STEC strains carrying intl1The plasmid profile analysis showed that all strains
carrying intl1 had 2e8 bands of high (>15 kb) and low
(<15 kb) molecular weights. Southern blot hybridization
assays indicated that a class 1 integron was located on plas-
mids in five of the seven strains (Fig. 2A,B). To see if
hybridization signal was detectable in chromosomal DNA,
genomic DNA incorporated in agarose plugs was digested
with I-CeuI and DNA fragments were separated by PFGE
(Shu-Lin et al., 1993). Southern blot hybridization indicated
that intl1 was not present in chromosomal DNA (data not
shown). To further confirm intl1-carrying plasmid, conjugation
experiments were performed using STEC strain Ec120/00 as
donor and E. coli HS as recipient. STEC strain Ec120/00
showed the presence of intl1 and resistance to streptomycin
and tetracycline (Table 1). Likewise, the transconjugant strain
Fig. 1. Dendrogram outlining the relationship of antibiotic-resistant O111 (A) and O118 (B) STEC strains from human and animal sources, determined by
macrorestriction analysis of genomic DNA with XbaI. *STEC strains carrying int/1.
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streptomycin and tetracycline resistance as detected by PCR
and disc diffusion (data not shown).
4. Discussion
Resistance genes can be associated with mobile DNA
plasmids, transposons and integrons, which are known to
facilitate their distribution (Guerra et al., 2006; Jacoby, 1994).
In the present study, almost 22% of STEC strains displaying
resistance to antimicrobials possessed a plasmid-carried class
1 integron (Fig. 2B), and most of these strains were isolated
from human infections and belonged to the O111 serogroup.This is the first description of a class 1 integron among STEC
strains isolated in Brazil. The presence of multi-drug resis-
tance, b-lactamase and class 1 integron-associated genes was
also recently described in some STEC serotypes isolated from
cattle feces and soil samples in Ireland (Scott et al., 2009). In
addition, Nagachinta and Chen (2008) determined that inte-
gron-mediated streptomycin and sulfisoxazole resistance
genes can be transferred from STEC strains belonging to
serotypes O157:H7 and O111:H8 to a susceptible E. coli K-12
strain in storm water and bovine feces.
The prevalence of the aadA1 gene cassette among class 1
integrons observed in the present study confirms previous
observations (Martinez-Freijo et al., 1998, 1999; Nagachinta
Fig. 2. Plasmid profiles of STEC strains carrying intl1. (A) Lanes 1 and 10, E. coli 39R861 strain carrying plasmids of known molecular sizes; 2, 502/80; 3,
1919/81; 4, Ec120/00; 5, 3691-5; 6 and 7, 21/85; 8, BY-1; 9, 2781-8 STEC strains. (B) Representative Southern blot hybridization assay with intI1-specific probe.
Lane 1, E. coli 39R861; lane 2, plasmid profile of STEC 1919/81 strain; lane 3, corresponding Southern blot hybridization.
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gene were found to be widely spread among STEC strains
isolated from humans, cattle, and food and belonging to
serogroups O26 and O111 (Morabito et al., 2002).
Similar antibiotic resistance patterns could be observed in
some of the animal and human isolates presently studied. It is
noteworthy that, although ampicillin and sulfonamides are old
antimicrobial compounds, they are still widely used. Although
these antimicrobial agents are more commonly used in the
treatment of humans than animals, more animal isolates
exhibited resistance (Maynard et al., 2004). Since 1983, when
the first blaTEM allele was identified (Sirot et al., 1987), several
variants of blaTEM that differ in amino acid sequence have been
identified (www.lahey.org/studies). However, TEM-1 is the
most commonly encountered b-lactamase in gram-negativeFig. 3. Representative agarose gel of amplified PCR products confirming the
transfer of intl1 by conjugation assay. Lane 1, 100-bp DNA ladder; 2, trans-
conjugant strain carrying intI1; 3, donor STEC strain Ec120/00; and 4,
recipient commensal strain E. coli HS.bacteria, and up to 90% of ampicillin resistance in E. coli is due
to the production of TEM-1 (Livermore, 1995). There are few
studies in the literature describing the presence of b-lactamase
in STEC. Ahmed et al. (2005) and Ishii et al. (2005) reported for
the first time a b-lactamase TEM-1 gene in EHEC O157 and an
ESBL CTX-M18-producing STEC isolate, respectively. Roest
et al. (2007) reported the presence of b-lactamase in E. coli
O157 isolated from chicken. In the present study, blaTEM was
carried by 34% of the STEC strains, and it was confirmed as the
b-lactamase TEM-1 gene by sequence analysis of one repre-
sentative STEC isolate. To the best of our knowledge, the
presence of the blaTEM-1 gene in ampicillin-resistant STEC
strains isolated from human infections has not been previously
described in our community.
Several PFGE profiles were identified among the O111 and
the O118 isolates studied. However, most of the strains in each
serogroup were grouped into the same cluster (80%e97%
similarity) and were classified into the phylogenetic group B1.
Interestingly, most of the O111 strains carrying intl1 were
clustered into two subgroups that showed more than 90%
similarity. In relation to the O118:H16 STEC isolates,
conclusions are more difficult to draw due to the low number
of strains, but it is interesting to note that the bovine strain
with intl1 displayed 80% similarity with the human isolate. In
addition, it should be mentioned that these two O118:H16
isolates were more distantly related (76.8%) to the multidrug-
resistant O118:H16 STEC strain previously described in South
America (Castro et al., 2003).
Although antimicrobial therapy is generally not recom-
mended for the treatment of STEC infections in humans, the
selection of multiresistant strains may contribute to the increase
in emerging antimicrobial-resistant pathogens, and may facili-
tate the spread of mobile resistance elements to other bacteria.
The presence of antimicrobial resistance genes among STEC
strains is worrisome, and no doubt plays a significant role in the
122 M.C. Cergole-Novella et al. / Research in Microbiology 162 (2011) 117e123acquisition and dissemination of new antimicrobial resistance.
Increased surveillance and the development of adequate
prevention strategies are warranted.Acknowledgments
We gratefully acknowledge the assistance of Anna Carolina
Kockskroh and Fernanda Marques Castrucci with the
dendrogram analysis and Fa´bia A. Salvador for helpful assis-
tance with the plasmid extraction. This study was supported by
grants from the Conselho Nacional de Desenvolvimento
Cientı´fico e Tecnolo´gico (CNPq), Coordenac¸a˜o de Aperfei-
c¸oamento de Pessoal de Nı´vel Superior (CAPES) and Pro-
grama de Apoio a Nu´cleos de Exceleˆncia (PRONEX MCT/
CNPq/FAPERJ) (to BECG). Dr. A. Leyva provided English
editing of the manuscript.References
Ahmed, A.M., Kawamoto, H., Inouye, K., Hashiwata, Y., Sakaki, M., Seno, M.,
Shimamoto, T., 2005. Genomic analysis of a multidrug-resistant strain of
enterohaemorrhagic Escherichia coliO157:H7 causing a family outbreak in
Japan. J. Med. Microbiol. 54, 867e872.
Aidar-Ugrinovich, L., Blanco, J., Blanco, M., Blanco, J.E., Leomil, L.,
Dahbi, G., Mora, A., Onuma, D.L., Silveira, W.D., de Castro, A.F.P.,
2007. Serotypes, virulence genes, and intimin types of shiga toxin-
producing Escherichia coli (STEC) and enteropathogenic E. coli (EPEC)
isolated from calves in Sa˜o Paulo, Brazil. Int. J. Food Microbiol. 115 (3),
297e306.
Beutin, L., Geier, D., Steinrck, H., Zimmermann, S., Scheutz, F., 1993.
Prevalence and some properties of verotoxin (shiga-like toxin)-producing
Escherichia coli in seven different species of healthy domestic animals. J.
Clin. Microbiol. 31, 2483e2488.
Beutin, L., Geier, D., Zimmermann, S., Aleksic, S., Gillespie, H.A.,
Whittam, T.S., 1997. Epidemiological relatedness and clonal types of
natural populations of Escherichia coli strains producing Shiga toxins in
separate populations of cattle and sheep. Appl. Environ. Microbiol. 63,
2175e2180.
Birnboim, H.C., Doly, J., 1979. A rapid alkaline extraction procedure for
screening recombinant plasmid DNA. Nucleic Acids Res. 7, 1513e1523.
Bonnet, R., 2004. Growing group of extended-spectrum b-lactamases: the
CTX-M enzymes. Antimicrob. Agents Chemother. 48, 1e14.
Bradford, P.A., 2001. Extended-spectrum b-lactamases in the 21st century:
characterization, epidemiology, and detection of this important resistance
threat. Clin. Microbiol. Rev. 14, 933e951.
Castanheira, M., Toleman, M.A., Jones, R.N., Schmidt, F.J., Walsh, T.R., 2004.
Molecular characterization of a b-lactamase gene, blaGIM-1, encoding
a new subclass of metallo-b-lactamase. Antimicrob. Agents Chemother.
48, 4654e4661.
Castro, A.F.P., Guerra, B., Leomil, L., Aidar-Ugrinovitch, L., Beutin, L., 2003.
Multidrug-resistant Shiga toxin-producing Escherichia coli 0118:H16 in
Latin America. Emerg. Infect. Dis. 9 (8), 1027e1028.
Cergole-Novella, M.C., Nishimura, L.S., Irino, K., Vaz, T.M.I., Castro, A.F.P.,
Leomil, L., Guth, B.E.C., 2006. Stx genotypes and antimicrobial resistance
profile of Shiga toxin-producing Escherichia coli strains isolated from
human infections, cattle and foods in Brazil. FEMS Microbiol. 259,
234e239.
Clermont, O., Bonacorsi, S., Bingen, E., 2000. Rapid and simple determination
of the Escherichia coli phylogenetic group. Appl. Environ. Microbiol. 66,
4555e4558.
Clinical and Laboratory Standards Institute, 2007. Performance Standards for
Antimicrobial Susceptibility Testing, 18th Informational Supplement.
Approved Standard M100eS16 (Wayne, PA, USA).Enne, V.I., Cassar, C., Sprigings, K., Woodward, M.J., Bennett, P.M., 2008.
A high prevalence of antimicrobial resistant Escherichia coli isolated
from pigs and a low prevalence of antimicrobial resistant E. coli from
cattle and sheep in Great Britain at slaughter. FEMS Microbiol. Lett. 278,
193e199.
Gautom, R.K., 1997. Rapid pulsed-field gel electrophoresis protocol for typing
of Escherichia coli O157:H7 and other gram-negative organisms in 1 day.
Clin. Microbiol. 35, 2877e2980.
Guerra, B., Junker, E., Schroeter, A., Helmuth, R., Guth, B.E.C., Beutin, L.,
2006. Phenotypic and genotypic characterization of antimicrobial resis-
tance in Escherichia coli O111 isolates. J. Antimicrob. Chemother. 57,
1210e1214.
Guth, B.E.C., Souza, R.L., Vaz, T.M.I., Irino, K., 2002. First Shiga toxin-
producing Escherichia coli isolate from a patient with hemolytic uremic
syndrome, Brazil. Emerg. Infect. Dis. 8, 535e536.
Irino, K., Kato, M.A., Vaz, T.M.I., Ramos, I.I., Souza, M.A., Cruz, A.S.,
Gomes, T.A., Vieira, M.A., Guth, B.E.C., 2005. Serotypes and virulence
markers of Shiga toxin-producing Escherichia coli (STEC) isolated from
dairy cattle in Sa˜o Paulo State, Brazil. Vet. Microbiol. 105, 29e36.
Irino, K., Vaz, T.M.I., Medeiros, M.I.C., Kato, M.A.M.F., Gomes, T.A.T.,
Vieira, M.A.M., Guth, B.E.C., 2007. Serotype diversity as a drawback in
the surveillance of Shiga toxin-producing Escherichia coli infections in
Brazil. J. Med. Microbiol. 56 (4), 565e567.
Ishii, Y., Kimura, S., Alba, J., Shiroto, K., Otsuka, M., Hashizume, N.,
Tamura, K., Yamaguchi, K., 2005. Extended-spectrum b-lactamase-
producing Shiga toxin gene (Stx1)-positive Escherichia coli O26:H11:
a new concern. J. Clin. Microbiol. 43, 1072e1075.
Jacoby, G.A., 1994. Genetics of extended-spectrum b-lactamases. Eur. J. Clin.
Microbiol. Infect. 13, S2eS11.
Kon, M., Kurazono, T., Ohshima, M., Yamaguchi, M., Morita, K.,
Watanabe, N., Kanamori, M., Matsushita, S., 2005. Cefotaxime-resistance
Shiga toxin-producing Escherichia coli O26:H11 isolated from a patient
with diarrhea. Kansenshogaku Zasshi 79, 161e168.
Lee, J.H., 2009. Antimicrobial resistance of Escherichia coli O26 and O111
isolates from cattle and their characteristics. Vet. Microbiol. 135, 401.
Leomil, L., Aidar-Ugrinovich, L., Guth, B.E.C., Irino, K., Vettorato, M.P.,
Onuma, D.L., de Castro, A.F.P., 2003. Frequency of Shiga toxin-producing
Escherichia coli (STEC) isolates among diarrheic and non-diarrheic calves
in Brazil. Vet. Microbiol. 97, 103e109.
Levine, M.M., Bergquist, E.J., Nalin, D.R., Waterman, D.H., Hornick, R.B.,
Young, C.R., Sotman, S., 1978. Escherichia coli strains that cause diarrhea
but do not produce heat-labile or heat-stable enterotoxins and are non-
invasive. Lancet 311, 1119e1122.
Livermore, D.M., 1995. b-Lactamases in laboratory and clinical resistance.
Clin. Microbiol. Rev. 8, 557e584.
Martinez-Freijo, P., Fluit, A.C., Schmitz, F.J., Grek, V.S., Verhoef, J.,
Jones, M.E., 1998. Class I integrons in gram-negative isolates from
different European hospitals and association with decreased susceptibility
to multiple antibiotic compounds. J. Antimicrob. Chemother. 42, 689e696.
Martinez-Freijo, P., Fluit, A.C., Schmitz, F.J., Verhoef, J., Jones, M.E., 1999.
Many class I integrons comprise distinct stable structures occurring in
different species of Enterobacteriaceae isolated from widespread
geographic regions in Europe. Antimicrob. Agents Chemother. 43,
686e689.
Maynard, C., Bekal, S., Sanschagrin, F., Levesque, R.C., Brousseau, R.,
Masson, L., Larivie`re, S., Harel, J., 2004. Heterogeneity among virulence
and antimicrobial resistance gene profiles of extraintestinal Escherichia
coli isolates of animal and human origin. J. Clin. Microbiol. 42,
5444e5452.
Morabito, S., Tozzoli, R., Caprioli, A., Karch, H., Carattoli, A., 2002.
Detection and characterization of class 1 integron in enterohemorrhagic
Escherichia coli. Microb. Drug Resist. 8, 85e91.
Nagachinta, S., Chen, J., 2008. Transfer of class 1 integron-mediated antibiotic
resistance genes from Shiga toxin-producing Escherichia coli to
a susceptible E. coli K-12 strain in storm water and bovine feces. Appl.
Environ. Microbiol. 74, 5063e5067.
Nagachinta, S., Chen, J., 2009. Integron-mediated antibiotic resistance in
Shiga toxin-producing Escherichia coli. Food Prot. 72, 21e27.
123M.C. Cergole-Novella et al. / Research in Microbiology 162 (2011) 117e123Nataro, J.P., Kaper, J.B., 1998. Diarrheagenic Escherichia coli. Clin. Micro-
biol. Rev. 11, 142e201.
Rasheed, J.K., Jay, C., Metchock, B., Berkowitz, F., Weigel, L., Crellin, J.,
Steward, C., Hill, B., Medeiros, A.A., Tenover, F.C., 1997. Evolution of
extended-spectrum beta-Lactam resistance (SHV-8) in a strain of Escher-
ichia coli during multiple episodes of bacteremia. Antimicrob. Agents
Chemother. 41, 647e653.
Roest, H.I., Liebana, E., Wannet, W., van Duynhoven, Y., Veldman, K.T.,
Mevius, D.J., 2007. Antibiotic resistance in Escherichia coli O157 isolated
between 1998 and 2003 in The Netherlands. Tijdschr Diergeneeskd 132,
954e958.
Salvadori, M.R., Valadares, G.F., Leite, D.S., Blanco, J., Yano, T., 2003.
Virulence factors of Escherichia coli isolated from calves with diarrhea in
Brazil. Braz. J. Microbiol. 34 (3), 230e235.
Scott, L., McGee, P., Walsh, C., Fanning, S., Sweeney, T., Blanco, J.,
Karczmarczyk, M., Earley, B., Leonard, N., Sheridan, J.J., 2009.
Detection of numerous verotoxigenic E. coli serotype, with multiple
antibiotic resistance from cattle faeces and soil. Vet. Microbiol. 134,
288e293.
Shu-Lin, L., Hessel, A., Sanderson, K.E., 1993. Genomic mapping with I-Ceu
I, an intron-encoded endonuclease specific for genes for ribosomal RNA,
in Salmonella spp., Escherichia coli, and other bacteria. Genetics 90,
6874e6878.
Sirot, D., Sirot, J., Labia, R., Morand, A., Courvalin, P., Darfeuille-
Michaud, A., Perroux, R., Cluzel, R., 1987. Transferable resistance to third
generation cephalosporins in clinical isolates of Klebsiella pneumoniae:identification of CTX-1, a novel beta-lactamase. J. Antimicrob. Chemo-
ther. 20, 323e334.
Srinivasan, V., Nguyen, L.T., Headrick, S.I., Murinda, S.E., Oliver, S.P., 2007.
Antimicrobial resistance patterns of shiga toxin-producing Escherichia
coli O157:H7 and O157:H7 from different origins. Microb. Drug Resist.
13, 44e51.
Van Den Bogaard, A.E., Stobberingh, E.E., 2000. Epidemiology of resistance
to antibiotics. Links between animals and humans. Int. J. Antimicrob.
Agents 14, 327e335.
Vaz, T.M.I., Irino, K., Kato, M.A., Dias, A.M., Gomes, T.A.T., Medeiros, M.I.,
Rocha, M.M.M., Guth, B.E.C., 2004. Virulence properties and character-
istics of shiga toxin-producing Escherichia coli in Sa˜o Paulo, Brazil, from
1976 through 1999. J. Clin. Microbiol. 42, 903e905.
Vinue´, L., Sa´enz, Y., Somalo, S., Escudero, E., Moreno, M.A., Ruiz-Larrea, F.,
Torres, C., 2008. Prevalence and diversity of integrons and associated
resistance genes in faecal Escherichia coli isolates of healthy humans in
Spain. J. Antimicrob. Chemother. 62, 934e937.
White, D.G., Zhao, S., Mcdermott, P.F., Ayers, S., Gaines, S., Friedman, S.,
Wagner, D.D., Meng, J., Needle, D., Davis, M., DebRoy, C., 2002.
Characterization of antimicrobial resistance among Escherichia coli O111
isolates of animal and human origin. Microb. Drug Resist. Summer 8,
139e146.
Zhao, S., White, D.G., Ge, B., Ayers, S., Friedman, S., English, L., Wagner, D.,
Gaines, S., Meng, J., 2001. Identification and characterization of integron-
mediated antibiotic resistance among Shiga toxin-producing Escherichia
coli isolates. Appl. Environ. Microbiol. 67, 1558e1564.
